Related Experiment Video

Updated: May 15, 2025

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
08:26

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression

Published on: February 17, 2012

14.4K

Potential target within the tumor microenvironment - MT1-MMP

Jinlong Liu1,2, Yijing Li1,2, Xueqi Lian1,2

  • 1School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.

Frontiers in Immunology
|April 8, 2025
PubMed

Insights

Matrix metalloproteinase 1 (MT1-MMP) is crucial for tumor progression and metastasis. Understanding its mechanisms is key to developing new targeted anti-cancer therapies, including cell-based approaches.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) modulate the tumor microenvironment, promoting cancer progression.
  • Membrane-type matrix metalloproteinase 1 (MT1-MMP/MMP14) is a key MMP involved in tumor infiltration and metastasis.
  • MT1-MMP overexpression correlates with poor prognosis in various cancers.

Purpose of the Study:

  • To review the structural characteristics and regulation of MT1-MMP expression.
  • To elucidate the biological significance of MT1-MMP in tumorigenesis.
  • To discuss current and future anti-cancer therapies targeting MT1-MMP.

Main Methods:

  • Literature review of studies on MT1-MMP structure, function, and therapeutic targeting.
  • Analysis of MT1-MMP's role in extracellular matrix degradation and immune cell recruitment.
  • Synthesis of information on MT1-MMP's involvement in tumor progression and metastasis.

Main Results:

  • MT1-MMP is essential for tumor cell invasion and metastasis by degrading the extracellular matrix.
  • Its expression is tightly regulated and linked to tumor aggressiveness.
  • Current research shows promise for MT1-MMP targeted therapies, though cell therapy applications are less explored.

Conclusions:

  • MT1-MMP is a critical target for anti-cancer drug development.
  • Further research into MT1-MMP's functional mechanisms will advance targeted cancer therapies.
  • Exploring MT1-MMP in cell therapy holds potential for novel treatment strategies.
Keywords:
MT1-MMP1extracellular matrix4metastasis5targeted therapy3tumor microenvironment2

More Related Videos

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

5.9K
Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System10:55

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System

Published on: January 8, 2018

10.9K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K